Nicholas Ashton
Affiliations: | University of Gothenburg, Gothenburg, Västra Götalands län, Sweden |
Google:
"Nicholas Ashton"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chong JR, Chai YL, Yam ATY, et al. (2024) Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 16: e12576 |
| Kac PR, González-Ortiz F, Emeršič A, et al. (2024) Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology. Nature Communications. 15: 2615 |
| Brum WS, Cullen NC, Therriault J, et al. (2024) A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings. Nature Communications. 15: 2311 |
| Therriault J, Schindler SE, Salvadó G, et al. (2024) Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nature Reviews. Neurology |
| Bastgen T, Evers J, Oedekoven C, et al. (2024) Repetitive head injuries in German American football players do not change blood-based biomarker candidates for CTE during a single season. Neurological Research and Practice. 6: 13 |
| Lantero-Rodriguez J, Salvadó G, Snellman A, et al. (2024) Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease. Molecular Neurodegeneration. 19: 19 |
| Ferrari-Souza JP, Brum WS, Hauschild LA, et al. (2024) Vascular risk burden is a key player in the early progression of Alzheimer's disease. Neurobiology of Aging. 136: 88-98 |
| Nilsson J, Pichet Binette A, Palmqvist S, et al. (2024) Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases. Brain : a Journal of Neurology |
| Coley N, Zetterberg H, Cantet C, et al. (2024) Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial. The Lancet. Healthy Longevity. 5: e120-e130 |
| Huber H, Blennow K, Zetterberg H, et al. (2024) Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |